Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery. - Wikidata - awgldk - TriplyDB

Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery.

Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery.

http://www.wikidata.org/entity/Q37018499

about

Restenosis Inhibition and Re-differentiation of TGFβ/Smad3-activated Smooth Muscle Cells by Resveratrol.Biomaterial-Based Approaches to Address Vein Graft and Hemodialysis Access Failures.Heparin-functionalized polymer graft surface eluting MK2 inhibitory peptide to improve hemocompatibility and anti-neointimal activity.Engineering Cardiovascular Implant Surfaces to Create a Vascular Endothelial Growth Microenvironment.Unimolecular Micelle-Based Hybrid System for Perivascular Drug Delivery Produces Long-Term Efficacy for Neointima Attenuation in Rats.Local honokiol application inhibits intimal thickening in rabbits following carotid artery balloon injury.Reduced arterial elasticity due to surgical skeletonization is ameliorated by abluminal PEG hydrogel.A review on core-shell structured unimolecular nanoparticles for biomedical applications

P2860

Q37626055-2EE1667E-2152-4485-A729-54E570453834 Q38817264-D294911D-EB3C-456D-BC80-EEFE10327138 Q47592103-F5F20670-6138-456E-8032-29E4FC4ADED0 Q47642689-17CFD5CC-F5F6-4847-8C6B-C51FD6ABC38A Q48019511-5CE8D32B-D8C8-4FFF-997E-5DAF7902188F Q50107012-D39471F8-D0AB-4C05-9B8B-40B0B47B4F1B Q55233314-D3304EDE-D2E6-4CA1-81F2-ADC7BCE33BB0 Q57179221-E5CF6FA2-7A30-4124-9FF7-92F18F789469

P2860

Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery.

http://www.wikidata.org/entity/Q37018499

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Periadventitial drug delivery ...... plasia following open surgery.

@en

Periadventitial drug delivery ...... plasia following open surgery.

@nl

type

label

Periadventitial drug delivery ...... plasia following open surgery.

@en

Periadventitial drug delivery ...... plasia following open surgery.

@nl

prefLabel

Periadventitial drug delivery ...... plasia following open surgery.

@en

Periadventitial drug delivery ...... plasia following open surgery.

@nl

P1433

Q37018499-B073944A-0747-4340-8869-A7DE96A4E225

P1476

Q37018499-7C87A754-7395-4B27-BACA-18597B46E160

P2093

Q37018499-1DED62C0-CA89-4F4F-B2DA-1B3E60F5AACC

Q37018499-2A9D4AF6-9482-4208-BBE7-83C316EE000B

Q37018499-5676C3ED-118C-458A-BE1C-E08CAB36509D

Q37018499-975EB7DC-5713-4980-9931-D7D06BC63E2D

Q37018499-AE7A1F70-D14D-4EB6-88CA-BC646138709B

Q37018499-B37B72DF-86C2-4E6F-8528-7CC15091E8A6

Q37018499-CE8EDBD0-139F-458F-B2CC-40F812A50D94

P2860

Q37018499-03940536-B768-401B-A061-4A1D1EFFB211

Q37018499-03F80736-5200-4D90-B7E4-33788E0512EC

Q37018499-09F2AD6B-23BC-48F9-8790-D7F07F5D969B

Q37018499-11AAB0B2-8E75-4EE4-AB4A-CF27E94E479A

Q37018499-235E0827-04CA-4EF6-9E7E-B987BE20693C

Q37018499-27E3F159-3795-4303-84BF-6833DFF404FD

Q37018499-27EE6C9C-6A88-4911-96AF-980CD2050EE0

Q37018499-43078748-0083-4174-AC81-A6F5265E103A

Q37018499-44BC220A-7F51-4992-A528-74443077ED6B

Q37018499-45C1F321-DA5E-45A2-A62E-35DB27B9C2DA

P304

Q37018499-AC18883B-43AA-4678-A0D5-2D9AAE24D994

P31

Q37018499-25D24164-E71A-4459-B53F-D38588458F1E

Q37018499-f3c19f7a-1905-42e3-bea9-7182aea3ae6f

P356

Q37018499-0B4B528E-F8B9-4DC4-B994-B4318B26B2C2

P407

Q37018499-15480091-7B8D-43AD-A2F3-E05862498E76

P478

Q37018499-0C765E15-E296-4253-B523-B24F63C44F50

P577

Q37018499-04A9D8A0-8CA5-4B29-97A5-A6A22B8380AE

P698

Q37018499-C3D734C2-FA2F-4327-BDD7-621B59D9622B

P921

Q37018499-ABBC5041-CB17-4781-B444-A6AA314BC971

P932

Q37018499-637BF21F-EFFF-485F-B762-0853B15AC9C5

P356

J.JCONREL.2016.05.002

P1433

Journal of Controlled Release

P1476

Periadventitial drug delivery ...... plasia following open surgery.

@en

P2093

Bo Liu

http://www.w3.org/2001/XMLSchema#string

Guojun Chen

http://www.w3.org/2001/XMLSchema#string

K Craig Kent

http://www.w3.org/2001/XMLSchema#string

Lian-Wang Guo

http://www.w3.org/2001/XMLSchema#string

Mirnal A Chaudhary

http://www.w3.org/2001/XMLSchema#string

Shaoqin Gong

http://www.w3.org/2001/XMLSchema#string

Xudong Shi

http://www.w3.org/2001/XMLSchema#string

P2860

A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics

Periadventitial application of rapamycin-loaded nanoparticles produces sustained inhibition of vascular restenosis

Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study

Nanoparticle therapeutics: an emerging treatment modality for cancer

Early adaptive responses of the vascular wall during venous arterialization in mice

Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications.

Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.

In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation.

Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasia.

Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft

P304

174-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2016.05.002

http://www.w3.org/2001/XMLSchema#string

P407

P478

233

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27179635

http://www.w3.org/2001/XMLSchema#string

P921

P932

4912910

http://www.w3.org/2001/XMLSchema#string